KVUE | tickerfilter.com

Fundamental analysis

39%

Profitability 30%

Dept financing 21%

Liquidity 25%

Performance 57%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.09%

1 Month

5.70%

3 Months

5.03%

6 Months

-0.86%

1 Year

15.50%

2 Year

-13.83%

Key data

Stock price

$23.18

P/E Ratio

39.68

DAY RANGE

$22.94 - $23.35

EPS

$0.54

52 WEEK RANGE

$17.67 - $24.46

52 WEEK CHANGE

$13.96

MARKET CAP

40.874 B

YIELD

3.80%

SHARES OUTSTANDING

1.915 B

DIVIDEND

$0.205

EX-DIVIDEND DATE

02-12-2025

NEXT EARNINGS DATE

N/A

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$15,221,938

AVERAGE 30 VOLUME

$17,173,691

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE
Industry: Consumer Goods/Perfumes, Cosmetics And Other Toilet Preparations
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc